IP Federation warns against ‘blanket ban’ on in-house counsel at UPC

UK trade association weighs in on Microsoft UPC appeal which deals with issue of representation | Former CIPA head says court should not “divide” European patent profession | SMEs could be forced to opt out patents due to counsel costs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Novartis stops rival’s launch of Entresto generic

16 January 2025 A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug.

Americas

MSN scores win in battle with Novartis over heart drug generic

22 October 2024 Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction.

Big Pharma

Novartis fails to block first heart-failure generic by Indian rival

13 August 2024 Delaware judge denies pharma giant’s request for injunction on rivals’ generic of Entresto | Novartis ‘unlikely to succeed’ in proving infringement | Lawsuit is one of several attempts to preserve exclusivity of the drug ahead of patent expiry and US price caps.